The European Centre for Disease Prevention and Control (ECDC) has published a call for tenders for molecular typing in surveillance and control of methicillin-resistant staphylococcus aureus (MRSA) in hospitals and the community.
The tasks related to this tender include:
- collating available evidence of the current use of different molecular typing methods for MRSA in the context of disease surveillance in the EU, and to assess how this evidence could be used as part of a model for integration of molecular typing data with epidemiological and clinical data on MRSA obtained in the EU;
- assessing and evaluating the usefulness of different molecular typing methods for hospital- and community-acquired MRSA strains for disease surveillance at the local/hospital level, at the national level and at the European level;
- assessing how integration of data from molecular typing of hospital- and community-acquired MRSA with epidemiological and clinical data obtained in the EU can be done at the local and European levels to enhance MRSA surveillance in the EU;
- conducting a pilot study in a small number of Member States to demonstrate the added value in relation to MRSA surveillance and control in the EU of integration of data from molecular typing of MRSA with epidemiological and clinical data.
For further information, please contact:
European Centre for Disease Prevention and Control
Tomtebodavägen 11a
Attn: Procurement
S-171 83 Stockholm
Tel. +46 858 60 1000
Fax +46 858 60 1001
E-mail: Contact
To see the full details of the call, please consult the following web address:
http://ted.europa.eu/udl?uri=TED:NOTICE:246099-2009:TEXT:EN:HTML
Remarks: The deadline for requesting tender documents is 9 October 2009.
The deadline for submitting tender documents is 19 October 2009.
Before contacting the Commission, tenderers are strongly advised to consult the original call text.
Category: Calls
Data Source Provider: Official Journal of the European Union
Document Reference: OJ No S 171-246099 of 5 September 2009
Subject Index: Forecasting; Evaluation; Safety; Medicine, Health
RCN: 31234
http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&DOC=36&CAT=NEWS&QUERY=0123d8dcbb4f:995e:0fb9bd50&RCN=31234
Related posts:
- Researchers identify molecular link between viral infection and cancer susceptibility A Portuguese-US research team has discovered a new molecular mechanism that enables gamma herpes viruses to chronically infect patients. Their research also offers a greater understanding of why these patients......
- Europe’s role in global S&T initiatives requires more EU funding, argues Potocnik Science and Research Commissioner Janez Potocnik has warned that Europe’s leading role in global science and technology initiatives such as ITER can only be maintained with sufficient funding at EU......
- ESF report warns of threats to Europe’s early leadership position in nanomedicine Europe is currently at the leading edge of advances in nanomedicine, an emerging area of technology with the potential to transform medical care and research, according to a newly published......
